IRVINE, Calif., July 18, 2017 -- Khang & Khang LLP (the “Firm”) announces a class action lawsuit against Mattel, Inc. (“Mattel” or the “Company”) (Nasdaq:MAT). Investors who purchased or otherwise acquired shares between October 20, 2016 and April 20, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the August 28, 2017 lead plaintiff motion deadline.
If you purchased Mattel shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250, Irvine, CA 92604, by telephone at (949) 419-3834, or by e-mail at [email protected].
There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.
According to the Complaint, during the Class Period, Mattel made false and/or misleading statements, and/or failed to disclose adverse information, including that the Company’s retail customers had high levels of unsold Mattel products, thus exposing it to the heightened risk that it would have to issue its retailers financial concessions to remove the excess inventory, and that it would experience slower sales growth in future periods. On April 20, 2017, Mattel announced its first quarter 2017 financial results, reporting declines for its worldwide net sales and gross margins on a year-over-year basis, and an increase of more than 158% in its operating loss. These results were well below Wall Street consensus estimates. When this news was announced, shares of Mattel fell in value materially, which caused investors harm according to the Complaint.
If you want to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or via e-mail at [email protected].
This press release may be considered Attorney Advertising in certain jurisdictions.
Contact Joon M. Khang, Esq. Telephone: 949-419-3834 Facsimile: 949-225-4474 [email protected]


Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 



